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This lack of editorial guidance results in a significant
amount of redundancy that limits the overall quality of the
text and makes it difficult to read from cover to cover.
Furthermore, there is a disproportionate emphasis on the
clinical sequelae of cardiac- and transplant-related
ischaemia-reperfusion injury. This may simply reflect the
level of investigation in these disciplines rather than the
bias of the editors or authors. However, the extensive dis-
cussion of hypothermia during cardiac surgery and solid
organ preservation solutions in the final section diverges
slightly from the central theme.
Despite these limitations, the text is a valuable resource
for individuals interested in ischaemia-reperfusion injury.
The editors have achieved their stated objectives of review-
ing the current clinical status of ischaemia-reperfusion
injury, exploring its pathophysiology, and outlining the
treatment strategies. In the process, they have edited a text
that is useful to both clinical and basic scientists.
Thomas Huber, MD
University of Florida
College of Medicine 
Gainesville, Fla
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Since the evolutionary origins of multicellular organ-
isms, stromal cells have inhabited matrix, that is to say,
connective tissue. Accordingly, virtually everything that
happens to us, from normal processes like embryologic
development and wound healing, to pathologic condi-
tions, like tumor invasion and metastasis, is associated with
tissue remodeling. Since the discovery of collagenase
(matrix metalloproteinase–1 = MMP-1) by Lapiere and
Gross in 1962, twenty MMPs have been characterized that
are responsible for many cell/matrix processes. Almost all
of our common diseases, like plaque disruption in athero-
sclerosis, joint destruction in various forms of arthritis,
and loss of alveolar ridge in periodontal disease, involve
MMPs. Presently, there is a dramatic crescendo of interest
in pharmacologic inhibition of MMP activity to alter the
natural history of dozens of diseases.
The present volume of more than 750 pages, pub-
lished as an Annals of the New York Academy of Sciences,
has more than 100 contributions from hundreds of coau-
thors. My “short” review of this compendium is that it is
a must for every scientist working in the MMP field. The
first 100 or so pages provide an authoritative account of
the basic science of MMPs and MMP inhibition, including
molecular models for MMP/inhibitor interactions and
complexities of structure/function relationships. The bal-
ance explores the potential for MMP inhibition in clinical
practice.
My favorite chapter was written by J. Frederick
Woessner, Jr, and is entitled “Matrix Metalloproteinase
Inhibition—From the Jurassic to the Third Millennium.”
He jests that he was invited to speak on this subject, since
he is a living dinosaur in the field, with a living recollec-
tion of the discovery of collagenase. The chapter is a splen-
did overview, with an interesting graphic that illustrates
the exponential growth over time in the rate of discovery
of new MMPs.
Shortly before the symposium in 1998 that gave birth
to this volume, the US Food and Drug Administration
approved doxycycline as an adjunct for periodontal dis-
ease, making it the first agent to be approved for use as a
collagenase inhibitor. I took an interest in the many chap-
ters on doxycycline, because my dentist recently pre-
scribed it to join the battle on my behalf in my own alve-
olar ridge wars. Sorsa and colleagues from Finland report-
ed an office “chairside” dipstick test for monitoring
MMP-8 activity in gingival crevicle fluid. Perhaps someday
we may see a dipstick test on patient serum to monitor
aneurysm inflammation.
There were several chapters relevant to research
endeavors in cardiovascular diseases. R. W. Thompson and
B. T. Baxter coauthored a fine chapter on the rationale for
a prospective, randomized clinical trial of doxycycline as an
inhibitor of aneurysm enlargement, with 83 timely refer-
ences. Loftus and colleagues has two interesting brief
communications. In the first, they reported that MMP
inhibition reduced myointimal hyperplasia in segments of
human saphenous vein cultured in vitro. In the second, in
a study correlating MMP levels in carotid endarterectomy
specimens with clinical symptomatology related to
embolization or plaque rupture, they found evidence for
increased MMP-9 in the group of most symptomatic
plaques.
Up my own alley, there was a chapter on enhanced
MMP expression in the aortas of apolipoprotein E
(apoE)–deficient mice with advanced atherosclerosis.
There have been claims by others that this mouse is a
model of aneurysm formation,1 but the published pho-
tomicrographs suggest that the lesion is a focal false
microaneurysm and not a true fusiform nonspecific
aneurysm with a degenerated adventitia. Also, I have seen
gross photographs of ectatic vessels in this mouse model,
taken in the laboratory of colleagues, and I am suspicious
that some of these ectatic lesions may be poststenotic
dilatations. Anyway, whether the mouse is a valid fusiform
aneurysm model or not, Thompson and Baxter make a
strong case in the previously mentioned chapter of doxy-
cycline in AAA in man.
So, in brief, in the tradition of New York Academy of
Sciences publications, this book defines state-of-the-art,
and I recommend it to all students of connective tissue
diseases.
David Tilson, MD
St Luke–Roosevelt Hospital Center 
New York, NY
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The contents of this beautifully produced quarto-sized
album will (or should be) old friends with many, if not
most, of the readers of the Journal of Vascular Surgery.
The book comprises an assemblage of 100 works of
visual art almost all paintings, in excellent four-color pho-
tographic reproduction, all having appeared on the cover
of JAMA between 1974 and 1987.
The practice of placing a reproduction of art on the
cover of the JAMA has, in fact, a longer history. It was the
happy inspiration of an earlier editor, John H. Talbutt, to
embellish the drab cover page of the journal with a pic-
ture, but the innovation was not carried out consistently
and there were no appraising comments printed to accom-
pany the illustrations.
The practice that brought forth the samples of visual
art displaying The Art of JAMA was initiated by a more
recent editor, Robert Moser, who invited M. Therese
Southgate to take on the task of selecting and comment-
ing on the cover pictures.
M. Therese Southgate had an outstanding potential
for one half of the job. She was a physician and an accom-
plished journalist, holding the position of deputy editor of
the journal, but had had no experience in the history of art
and in art criticism. Before meeting the challenge of this
new assignment, she imposed on herself a rigorous sys-
tematic study of art history and art appraisal, which she
pursued with unrelenting zeal for several months, until she
felt ready to begin her new career. Her first selection and
commenting essay appeared on the cover of the December
16, 1974, issue of the Journal of the American Medical
Association.
Those who have since found pleasure in delving into
the technical minutiae and artistic images of the 100
selected cover reproductions as interpreted in Dr
Southgate’s comments have learned that she had prepared
herself for the new assignment with eminent success.
A visual journey through the volume eloquently
demonstrates that Dr Southgate’s judgment in choosing
was singularly sound. Masterpieces selected for the read-
er’s review represent every school of creative approach to
visual art since the Middle Ages to the present. Whether
by design or accident, the selections are not ordered
chronologically or by genres, and the contrast between the
selection as they follow one another noticeably raises the
level of the viewer’s appreciation of their distinctive char-
acters. The typographic quality of the reproductions is as
fine as one can desire. The essays that face the reproduc-
tions place the art work in its historic background and
sketch the life and work of the artists. The narrative is
clear, concise, and brilliantly illuminating. As the essayist
smoothly dissects the anatomy of technical details, the
reader and viewer begin to see the picture in a revealing
new light.
In general, the selections show no planned orientation
to medical subjects specifically. There are only four that fall
in this category, but two of these deserve particular notice.
One is Thomas Elkin’s portrait of Samuel Gross (perhaps
the best known American surgeon of the 19th century),
and the other is Pablo Picasso’s early-career Science and
Charity, a sort of later extension of the theme of the
immortal The Doctor by Sir Luke Fildes (which is also
reproduced). To those who know Picasso by his later
works, secretly suspecting that he painted the way he did
because he know no better, the superb technical details of
this painting will be a surprising revelation.
Between December 16, 1974, and December 11,
1987, 676 reproductions of pieces of art appeared on the
cover of JAMA. Dr Southgate selected and commented
on all but a handful of these.
The question naturally arises about the appropriate-
ness of the presence of the art on the cover of a scientific
periodical. This questions must have often been asked of
Dr Southgate, for she wrote several paragraphs in the pref-
ace of the book to demonstrate an essential, though rather
mystic, affinity between the work of the artist and the
physician. Her argument is very ingenious, but rather
complex to follow.
This reviewer admits to a fundamental, but hard to
identify similarity in the inner forces that determine the
ultimate goal of the work of the physician and the artist:
they both deal with reconciling imperfections of life
(health and disease in man for the physician; order and dis-
order in the physical world for the artist). Also, aside from
abstruse interpretations, there are empirical facts that sug-
gest not only attraction, but a deeper relationship between
the two: physicians take up the amateur practice of art
(mostly painting) much more often than members of
other professions, and they are disproportionately fre-
quent sponsors of art.
But in our daily living the recognition of such a kin-
ship is not a requirement for welcoming art on the cover
of a medical journal. The rare moment of pleasure that the
appearance of great art on the cover offers is triumphant
justification for its presence.
D. Emerick Szilagyi, MD
Bloomfield Hills, Mich
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